, The European Union Committee of Experts on Rare Diseases: three productive years at the service of the rare disease community, Orphanet Journal of Rare Diseases, vol.9, issue.1, p.30, 2014.
DOI : 10.1186/1750-1172-9-30
, Genes involved in leukodystrophies: A glance at glial functions, Current Neurology and Neuroscience Reports, vol.354, issue.3, pp.217-229, 2008.
DOI : 10.1007/s11910-008-0034-x
, Childhood leukodystrophies: a clinical perspective, Expert Review of Neurotherapeutics, vol.11, issue.10, pp.1485-1496, 2011.
DOI : 10.1586/ern.11.135
, Data storage and DNA banking for biomedical research: informed consent, confidentiality, quality issues, ownership, return of benefits. A professional perspective, European Journal of Human Genetics, vol.11, pp.88-122, 2003.
DOI : 10.1038/sj.ejhg.5201114
, International charter of principles for sharing bio-specimens and data, Eur J Hum Genet, pp.1-8, 2014.
, Data protection legislation: interpretation and barriers to research, BMJ, vol.321, issue.7265, pp.890-892, 2000.
DOI : 10.1136/bmj.321.7265.890
, Maintaining privacy and the health of the public, BMJ, vol.316, issue.7141, pp.1331-1332, 1998.
DOI : 10.1136/bmj.316.7141.1331
, Ethical management in the constitution of a European database for leukodystrophies rare diseases, European Journal of Paediatric Neurology, vol.18, issue.5, pp.97-603, 2014.
DOI : 10.1016/j.ejpn.2014.04.002
URL : https://hal.archives-ouvertes.fr/inserm-00995366
, EURO-WABB: an EU rare diseases registry for Wolfram syndrome, Alstr??m syndrome and Bardet-Biedl syndrome, BMC Pediatrics, vol.30, issue.Supp 2, p.130, 2013.
DOI : 10.1007/s10545-007-0521-2
, Communication of pharmacogenetic research results to HIV-infected treated patients: standpoints of professionals and patients, European Journal of Human Genetics, vol.11, issue.9, pp.1055-1062, 2005.
DOI : 10.1038/sj.ejhg.5201450
URL : https://hal.archives-ouvertes.fr/inserm-00000049
, Clinical research for rare disease: Opportunities, challenges, and solutions, Molecular Genetics and Metabolism, vol.96, issue.1, pp.20-26, 2009.
DOI : 10.1016/j.ymgme.2008.10.003
, The UK Biobank project: Trust and altruism are alive and well, International Journal of Surgery, vol.7, issue.6, pp.501-502, 2009.
DOI : 10.1016/j.ijsu.2009.09.001
, Optimizing treatments in rare diseases: Will our evidence come from registry data?, Leukemia Research, vol.38, issue.4, pp.421-422, 2014.
DOI : 10.1016/j.leukres.2014.01.015
, The TREAT-NMD Duchenne Muscular Dystrophy Registries: Conception, Design, and Utilization by Industry and Academia, Human Mutation, vol.115, issue.3-4, pp.1449-1457, 2013.
DOI : 10.1002/humu.22390
, Patient and Public Views on Electronic Health Records and Their Uses in the United Kingdom: Cross-Sectional Survey, Journal of Medical Internet Research, vol.15, issue.8, p.160, 2013.
DOI : 10.2196/jmir.2701
, The Need to Downregulate: A Minimal Ethical Framework for Biobank Research, Methods Mol Biol, vol.675, pp.39-59, 2010.
DOI : 10.1007/978-1-59745-423-0_2
, One-Time General Consent for Research on Biological Samples, Archives of Internal Medicine, vol.166, issue.14, pp.1449-1452, 2006.
DOI : 10.1001/archinte.166.14.1449
, Informed Consent in Genome-Scale Research: What Do Prospective Participants Think?, AJOB Primary Research, vol.162, issue.13, pp.3-11, 2012.
DOI : 10.1080/21507716.2012.662575
, Ethics and biobanks, British Journal of Cancer, vol.5, issue.1, pp.8-12, 2008.
DOI : 10.1111/j.1748-720X.2008.00266.x
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2634684
, Publics and biobanks: Pan-European diversity and the challenge of responsible innovation, European Journal of Human Genetics, vol.5, issue.1, pp.14-20, 2013.
DOI : 10.1183/09031936.00165006
, Guidance in Social and Ethical Issues Related to Clinical, Diagnostic Care and Novel Therapies for Hereditary Neuromuscular Rare Diseases: ???Translating??? the Translational, PLoS Currents, vol.10, p.5, 2013.
DOI : 10.1371/currents.md.f90b49429fa814bd26c5b22b13d773ec
, Informed consent and patient registry for the rare disease community: Editorial, Contemporary Clinical Trials, vol.33, issue.1, pp.3-4, 2011.
DOI : 10.1016/j.cct.2011.10.005
, Agency for Healthcare Research and Quality (US): Rockville (MD) 2014, Registries for evaluating patient outcomes, 208616.
, Public health and the law. Informed consent and blanket consent forms., American Journal of Public Health, vol.61, issue.6, pp.1245-1246, 1971.
DOI : 10.2105/AJPH.61.6.1245
, Gene banks and blanket consent, Nat Rev Genet, vol.3, p.577, 2002.
, Ethical aspects of participation in the Database of Genotypes and Phenotypes of the National Center for Biotechnology Information, Cancer, vol.60, issue.20, pp.5060-5068, 2012.
DOI : 10.1002/cncr.27515
, Building on relationships of trust in biobank research, Journal of Medical Ethics, vol.31, issue.7, pp.415-418, 2005.
DOI : 10.1136/jme.2004.009456
, Biobanks, consent and claims of consensus, Nature Methods, vol.140, issue.9, pp.885-888, 2012.
DOI : 10.1097/GIM.0b013e31821d2f88
, Broad consent versus dynamic consent in biobank research: Is passive participation an ethical problem?, European Journal of Human Genetics, vol.17, issue.4, pp.897-902, 2013.
DOI : 10.1136/bmj.e3502
, Dynamic consent: a patient interface for twenty-first century research networks, European Journal of Human Genetics, vol.23, issue.2, pp.1-6, 2014.
DOI : 10.1542/peds.2007-3860
, Informed Consent in the Genomics Era, PLoS Medicine, vol.6, issue.9, p.192, 2008.
DOI : 10.1371/journal.pmed.0050192.sd002